low doses of stroma - free diaspirin cross - linked hemoglobin are administered to patients undergoing hemodialysis , to achieve hemostabilization and avoid hypotensive episodes in susceptible patients . hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability .